sellWeak cluster of 410b5-1 plan
Saurabh Saha sold $695k of CNTA
Chief Executive Officer at Centessa Pharmaceuticals plc. 55,000 shares at an average of $12.63, traded Jun 20, 2025, filed Jun 20, 2025.
Warning score
31Value
$695k
55,000 shares
Holdings after
221,017
-20% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +21Trade size$695k at market
- +5Share of holdings soldSold 20% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001847903-25-000095, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 20, 2025 | MOption exercise Ordinary Shares10b5-1 | +55,000 | $3.85 | $212k | 276,017 | Jun 20, 2025 |
| Jun 20, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -55,000 | $12.63 | $695k | 221,017 | Jun 20, 2025 |
| Jun 20, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -55,000 | $0.00 | $0 | 205,000 | Jun 20, 2025 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 14Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $288k 10,000 shares | -5% | |
| 0Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $300k 10,000 shares | -5% | |
| 18Weak | Centessa Pharmaceuticals plc | Tia L Bush Chief Technology & Quality Ofc | $1.1M 40,000 shares | -25% | |
| 0Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $166k 6,000 shares | -5% | |
| 18Weak | Centessa Pharmaceuticals plc | Tia L Bush Chief Technology & Quality Ofc | $1.0M 40,000 shares | -25% | |
| 5Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $200k 8,000 shares | -4% | |
| 0Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $134k 6,000 shares | -5% | |
| 23Weak | Centessa Pharmaceuticals plc | Tia L Bush Chief Technology & Quality Ofc | $840k 35,000 shares | -22% | |
| 26Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $175k 8,172 shares | -4% | |
| 6Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $131k 6,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.